Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.

Wang X, Hripcsak G, Markatou M, Friedman C.

J Am Med Inform Assoc. 2009 May-Jun;16(3):328-37. doi: 10.1197/jamia.M3028. Epub 2009 Mar 4.

2.

Using text-mining techniques in electronic patient records to identify ADRs from medicine use.

Warrer P, Hansen EH, Juhl-Jensen L, Aagaard L.

Br J Clin Pharmacol. 2012 May;73(5):674-84. doi: 10.1111/j.1365-2125.2011.04153.x. Review.

3.

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC.

Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Review.

4.

Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.

Luo Y, Thompson WK, Herr TM, Zeng Z, Berendsen MA, Jonnalagadda SR, Carson MB, Starren J.

Drug Saf. 2017 Jun 22. doi: 10.1007/s40264-017-0558-6. [Epub ahead of print] Review.

PMID:
28643174
5.

Detecting adverse events using information technology.

Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G.

J Am Med Inform Assoc. 2003 Mar-Apr;10(2):115-28. Review.

6.

Application of data mining techniques in pharmacovigilance.

Wilson AM, Thabane L, Holbrook A.

Br J Clin Pharmacol. 2004 Feb;57(2):127-34. Review.

7.

Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?

Coloma PM, Trifirò G, Patadia V, Sturkenboom M.

Drug Saf. 2013 Mar;36(3):183-97. doi: 10.1007/s40264-013-0018-x. Review.

PMID:
23377696
8.

Adverse drug events and medication errors in Australia.

Runciman WB, Roughead EE, Semple SJ, Adams RJ.

Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. Review.

PMID:
14660523
9.

Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.

Awada Z, Zgheib NK.

Pharmacogenomics. 2014 Apr;15(6):845-56. doi: 10.2217/pgs.14.44. Review.

PMID:
24897290
10.

Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.

Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Fornari C, Pedersen L, van der Lei J, Sturkenboom M, Trifirò G; EU-ADR consortium.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102. doi: 10.1586/17512433.2015.992878. Review.

PMID:
25487079
11.

Identifying drug safety issues: from research to practice.

Gandhi TK, Seger DL, Bates DW.

Int J Qual Health Care. 2000 Feb;12(1):69-76. Review.

PMID:
10733086
12.
13.

"Big data" and the electronic health record.

Ross MK, Wei W, Ohno-Machado L.

Yearb Med Inform. 2014 Aug 15;9:97-104. doi: 10.15265/IY-2014-0003. Review.

14.

Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.

Lai EC, Pratt N, Hsieh CY, Lin SJ, Pottegård A, Roughead EE, Kao Yang YH, Hallas J.

Eur J Epidemiol. 2017 Jul 11. doi: 10.1007/s10654-017-0281-8. [Epub ahead of print] Review.

PMID:
28698923

Supplemental Content

Support Center